ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
18.163,52
-0,41%
S&P 500
5.464,62
-0,16%
Dow Jones
39.150,33
0,04%
Euro vs US Dollar
1,06863
-0,06%
Bitcoin
64.087,94
-0,24%
Registration Strip Icon for alerts Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NYSE
  6. Haemonetics Corp (HAE)

  7. Haemonetics Corp (HAE) News

HAE Haemonetics Corp

85,19
-0,31 (-0,36%)
22 Jun 2024 - Geschlossen
Verzögert um 15 Minuten
Name Symbol Markt Aktientyp
Haemonetics Corp HAE NYSE Common Stock
  Änderung Änderung % Aktuell Zeit
Upgrade Icon
-0,31 -0,36% 85,19 02:00:00
Handelsbeginn Niedrig Hoch Schlusskurs Handelsende
86,11 84,98 86,86 85,19 85,50
more quote information »

Aktuelle News

Datum Zeit Quelle Überschrift
18.6.202422:15PRNUSHaemonetics Launches Limited Market Release for New VASCADE..
07.6.202422:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07.6.202412:31EDGAR2Form ARS - Annual Report to Security Holders
07.6.202412:30EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
07.6.202412:26EDGAR2Form DEF 14A - Other definitive proxy statements
29.5.202423:44EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29.5.202423:42EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29.5.202423:38EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29.5.202423:35EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29.5.202423:31EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29.5.202423:27EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29.5.202422:06EDGAR2Form 8-K - Current report
29.5.202417:06EDGAR2Form 144 - Report of proposed sale of securities
29.5.202416:24EDGAR2Form 144 - Report of proposed sale of securities
28.5.202422:34EDGAR2Form SD - Specialized disclosure report
23.5.202412:03EDGAR2Form 8-K - Current report
23.5.202412:00PRNUSHaemonetics Prices Upsized Private Placement of $600 Million..
22.5.202412:37IHMARKETNEWSNvidia Profits Set to Challenge Historic High Market; GE..
22.5.202400:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22.5.202400:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21.5.202423:58EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21.5.202423:55EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21.5.202423:52EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21.5.202423:49EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21.5.202423:46EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21.5.202423:41EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21.5.202423:38EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21.5.202422:06EDGAR2Form 8-K - Current report
21.5.202422:05PRNUSHaemonetics Announces Proposed Convertible Senior Notes..
20.5.202417:24EDGAR2Form 144 - Report of proposed sale of securities
20.5.202417:13EDGAR2Form 144 - Report of proposed sale of securities
20.5.202416:45EDGAR2Form 144 - Report of proposed sale of securities
20.5.202412:16EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
17.5.202423:11EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17.5.202423:08EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17.5.202423:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17.5.202423:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17.5.202422:58EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17.5.202422:55EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17.5.202422:52EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17.5.202422:46EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17.5.202422:39EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17.5.202418:15EDGAR2Form 144 - Report of proposed sale of securities
17.5.202416:07EDGAR2Form 144 - Report of proposed sale of securities
16.5.202418:57EDGAR2Form 144 - Report of proposed sale of securities
16.5.202418:15EDGAR2Form 144 - Report of proposed sale of securities
16.5.202418:12EDGAR2Form 144 - Report of proposed sale of securities
09.5.202412:04EDGAR2Form 8-K - Current report
09.5.202412:00PRNUSHaemonetics 4th Quarter and Fiscal Year 2024 Earnings..
08.5.202422:21EDGAR2Form 4 - Statement of changes in beneficial ownership of..

Kürzlich von Ihnen besucht

NYSE
HAE
Haemonetics
COIN
BSDUSD
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2024 ADVFN PLC - Alle Rechte vorbehalten